CGUARDIANS III IDE Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 103 participants.

Also called NCT07277296

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 103 participants (planned count) (from the registry)
Sponsor
  • InspireMD Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07277296
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07277296. Allocation not applicable; no masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2027-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CGUARDIANS III IDE Pivotal Trial
Condition
Carotid Artery Stenosis
Intervention (Device)
SwitchGuardTM NPS
Lead sponsor
InspireMD (class: industry)

Record details

Record id
cardio:ct-nct07277296
Content hash
60a78967c43d1e0242b268a00e870463a4d026187162aa1260367aba971c19b3